Todd Goldberg

Todd Goldberg has a strong background in market access and pharmaceuticals. Todd currently holds the position of Vice President, Market Access at Deciphera Pharmaceuticals. Prior to this, they worked at Agios Pharmaceuticals as a Vice President, where they led the global market access function and was responsible for the launch of Tibsovo in two AML indications. Before Agios, Todd was the VP Market Access at Clovis Oncology, where they built access infrastructure and launch plans for novel oral oncolytic products. Todd also worked at Amgen for several years, holding roles such as Executive Director Corporate Accounts and Payor Reimbursement and Executive Director, Marketing. Throughout their career, Todd has demonstrated strong leadership skills and expertise in market access, strategic planning, and brand management.

Todd Goldberg attended Harvard Business School from 1991 to 1993, where they earned an MBA in General Management. Prior to that, they studied Biomedical Engineering at Northwestern University from 1986 to 1989, and obtained an MSE degree. Todd completed their undergraduate education at the University of Pennsylvania from 1983 to 1986, majoring in Bioengineering and earning a BSE degree.